Targeting toll-like receptor 2 and its crosstalk with the cystine/glutamate antiporter XCT as new combined therapy for breast cancer

Scriptie/Masterproef: Master's Thesis

Datum prijs23 mei 2022
Originele taalEnglish
BegeleiderFederica Cavallo (Promotor), Ann Massie (Promotor), Laura Conti (Co-promotor) & Antonio Di Lorenzo (Advisor)

Citeer dit

'